These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18079486)

  • 21. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
    Sakata N; Moh A; Takebayashi S
    Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction.
    Glomb MA; Monnier VM
    J Biol Chem; 1995 Apr; 270(17):10017-26. PubMed ID: 7730303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of N(ε)-(carboxymethyl)lysine formation in aqueous model systems of sugars and casein.
    Nguyen HT; van der Fels-Klerx HJ; van Boekel MA
    Food Chem; 2016 Feb; 192():125-33. PubMed ID: 26304329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
    van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
    Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
    Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
    Tanimoto M; Gohda T; Kaneko S; Hagiwara S; Murakoshi M; Aoki T; Yamada K; Ito T; Matsumoto M; Horikoshi S; Tomino Y
    Metabolism; 2007 Feb; 56(2):160-7. PubMed ID: 17224327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal.
    Nagaraj RH; Sarkar P; Mally A; Biemel KM; Lederer MO; Padayatti PS
    Arch Biochem Biophys; 2002 Jun; 402(1):110-9. PubMed ID: 12051689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of N epsilon-(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes.
    Hwang JS; Shin CH; Yang SW
    Diabetes Obes Metab; 2005 May; 7(3):263-7. PubMed ID: 15811143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site specificity of glycation and carboxymethylation of bovine serum albumin by fructose.
    Hinton DJ; Ames JM
    Amino Acids; 2006 Jun; 30(4):425-34. PubMed ID: 16583308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunochemical detection of Nepsilon-(carboxyethyl)lysine using a specific antibody.
    Nagai R; Fujiwara Y; Mera K; Yamagata K; Sakashita N; Takeya M
    J Immunol Methods; 2008 Mar; 332(1-2):112-20. PubMed ID: 18242632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
    Koito W; Araki T; Horiuchi S; Nagai R
    J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma concentration and urinary excretion of N epsilon-(carboxymethyl)lysine in breast milk- and formula-fed infants.
    Sebeková K; Saavedra G; Zumpe C; Somoza V; Klenovicsová K; Birlouez-Aragon I
    Ann N Y Acad Sci; 2008 Apr; 1126():177-80. PubMed ID: 18448813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxynitrite induces formation of N( epsilon )-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite.
    Nagai R; Unno Y; Hayashi MC; Masuda S; Hayase F; Kinae N; Horiuchi S
    Diabetes; 2002 Sep; 51(9):2833-9. PubMed ID: 12196478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N epsilon-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis.
    Motomiya Y; Oyama N; Iwamoto H; Uchimura T; Maruyama I
    Kidney Int; 1998 Oct; 54(4):1357-66. PubMed ID: 9767556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of CML contents in the Maillard reaction products for casein-monosaccharides model.
    Oh MJ; Kim Y; Hoon Lee S; Lee KW; Park HY
    Food Chem; 2018 Nov; 267():271-276. PubMed ID: 29934167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
    Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
    Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
    Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
    Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of inhibitor compounds on Nε-(carboxymethyl)lysine (CML) and Nε-(carboxyethyl)lysine (CEL) formation in model foods.
    Srey C; Hull GL; Connolly L; Elliott CT; del Castillo MD; Ames JM
    J Agric Food Chem; 2010 Nov; 58(22):12036-41. PubMed ID: 21043504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N(ε)-Carboxymethyllysine (CML), a Maillard reaction product, stimulates serotonin release and activates the receptor for advanced glycation end products (RAGE) in SH-SY5Y cells.
    Holik AK; Rohm B; Somoza MM; Somoza V
    Food Funct; 2013 Jul; 4(7):1111-20. PubMed ID: 23759926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.